Oral Candida dubliniensis as a clinically important species in HIV-seropositive patients in the United States. (Q54072772)

24 May 2018

title

Oral Candida dubliniensis as a clinically important species in HIV-seropositive patients in the United States. (English)

1 reference

24 May 2018

main subject

patient

0 references

United States of America

0 references

Candida dubliniensis

object named as

Candida dubliniensis

1 reference

Meiller TF

1

1 reference

24 May 2018

Jabra-Rizk MA

2

1 reference

24 May 2018

Baqui A

3

1 reference

24 May 2018

Kelley JI

4

1 reference

24 May 2018

Meeks VI

5

1 reference

24 May 2018

Merz WG

6

1 reference

24 May 2018

Falkler WA

7

1 reference

24 May 2018

publication date

1 November 1999

1 reference

24 May 2018

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

published in

1 reference

24 May 2018

volume

88

1 reference

24 May 2018

issue

5

1 reference

24 May 2018

page(s)

573-580

1 reference

24 May 2018

HIV infection of monocyte-derived macrophages in vitro reduces phagocytosis of Candida albicans

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Plasma virus load evaluation in relation to disease progression in HIV-infected children

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Association of cutaneous and oral diseases in HIV-infected men

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

HIV-associated oral lesions; immunologic, virologic and salivary parameters

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Identification of Candida dubliniensis in a prospective study of patients in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Candida albicans strain delineation

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Nosocomial Candida glabrata colonization: an epidemiologic study.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Candida tropicalis: A Major Pathogen in Immunocompromised Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

1 reference

7 January 2021

Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Comparison of four DNA-based methods for strain delineation of Candida lusitaniae.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Candida dubliniensis: phylogeny and putative virulence factors

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Fluconazole-resistant Candida species in the oral flora of fluconazole-exposed HIV-positive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Demographics of HIV-infected persons attending a dental clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Oral manifestations of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Oral diseases, mycology and periodontal microbiology of HIV-1-infected women

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970088-0

7 January 2021

10.1016/S1079-2104(99)70088-0

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018